Inherited Retinal Disease: What to Expect From Testing

Hearing the words “inherited retinal disease” (IRD) can feel like the floor just moved a little under your feet.
Suddenly there are new terms to learn, tests to consider, and decisions to make for yourself and sometimes for your
whole family. One of the most important tools your care team may recommend is genetic testing for IRD.

The good news? IRD genetic testing is usually straightforward (no sci-fi level machines involved), and the information
it provides can be incredibly powerful. It can confirm or refine your diagnosis, help predict how your vision may change,
open the door to clinical trials or gene therapy, and give clearer answers about risks for children or other relatives.

This guide walks you through what inherited retinal diseases are, why genetic testing matters, and exactly what to expect
before, during, and after testingso you can go into the process informed, prepared, and a little less stressed.

What Is an Inherited Retinal Disease?

Inherited retinal diseases are a group of eye conditions caused by changes (mutations) in genes that are important for
the health and function of the retina, the light-sensing layer at the back of your eye. These conditions are
“inherited” because the gene changes can be passed down through families.

IRDs are rare individually, but taken together they’re a leading cause of severe vision loss in working-age adults.
There are more than 300 known genes linked to IRDs, and that list is still growing as research continues.

Common Types of Inherited Retinal Disease

• Retinitis pigmentosa (RP) – A group of disorders that often begin with night blindness and loss of peripheral vision.
• Stargardt disease – Typically affects central vision first, often in children or young adults.
• Leber congenital amaurosis (LCA) – A severe, early-onset IRD that can cause significant vision loss in infancy or early childhood.
• Usher syndrome – Combines a retinal disease (usually RP) with hearing loss.
• Cone-rod dystrophies and other macular dystrophies – Affect detailed and color vision, often impacting reading and driving vision.

Even within the same diagnosis, symptoms and age of onset can vary widely between individuals and families. That’s one
reason genetic testing has become so important: it helps clarify which specific gene and mutation are involved, not just
the broad disease label.

Why Genetic Testing Matters for Inherited Retinal Disease

Genetic testing for IRD means analyzing your DNAusually from a blood, saliva, or cheek-swab sampleto look for changes
in genes known to be associated with inherited retinal diseases.

1. Getting a Precise, “Molecular” Diagnosis

A clinical eye exam and imaging can suggest an IRD, but different IRDs often look similar in the early stages.
Genetic testing can:

• Confirm that your retinal condition is inherited.
• Identify the exact gene and mutation causing your disease.
• Distinguish between conditions that appear similar under the microscope or on imaging.

This is sometimes called getting a molecular diagnosis, and it’s increasingly considered a key part of
standard care for many IRDs.

2. Guiding Treatment, Gene Therapy, and Clinical Trials

Many emerging treatments for IRDs, particularly gene therapies, are designed to target a specific gene.
Without genetic testing, it’s impossible to know whether you’re even eligible for these options.

For example, FDA-approved gene therapy for certain forms of LCA caused by RPE65 mutations requires genetic confirmation
that the RPE65 gene is the problem. Other gene therapiesand even some of the newest experimental treatments for
conditions like AIPL1-related LCAalso rely heavily on knowing the exact gene change.

3. Understanding Inheritance and Family Risk

IRDs can be inherited in different ways: autosomal dominant, autosomal recessive, X-linked, or rarely mitochondrial.
Each pattern carries different implications for who else in the family may be at risk.

Genetic testing results, combined with genetic counseling, can help you answer questions like:

• “What are the chances my children could inherit this condition?”
• “Should my siblings or other relatives consider testing?”
• “What does this mean for future family planning?”

This information can be emotionally heavy, but it can also empower families to plan, screen earlier, and access support
sooner rather than later.

4. Contributing to Research and Future Therapies

When people with IRDs undergo genetic testing and join registriessuch as the My Retina Tracker® Registry supported by
the Foundation Fighting Blindnessit helps researchers better understand how common certain mutations are and which
treatments might be most needed.

In other words, your test result isn’t just a piece of paperit can also be one pixel in the bigger research picture
that drives new therapies forward.

How Genetic Testing for IRD Works: Step by Step

While every clinic does things a little differently, most people go through a similar series of steps. Here’s what you
can expect from start to finish.

Step 1: Referral and Comprehensive Eye Exam

The process usually begins when an eye care professionaloften an ophthalmologist or retinal specialistsuspects an IRD
based on your symptoms, retinal imaging, and family history.

At this visit, you may have:

• Visual acuity testing (how clearly you see letters on the chart).
• Visual field testing to check peripheral vision.
• Retinal imaging (such as OCT or wide-field photography).
• Electroretinography (ERG) to measure how your retina responds to light.

Based on these results and your family history, your doctor may recommend genetic testing and refer you to a genetic
counselor or specialized IRD clinic.

Step 2: Pre-Test Genetic Counseling

Before your DNA is collected, you’ll usually meet with a genetic counselor or specially trained eye care provider.

In this session, you can expect to talk about:

• Your personal and family history of vision problems (and other medical issues if relevant).
• How genetic testing works and what it can and cannot answer.
• Possible outcomes of testing (positive, negative, or uncertain results).
• Privacy, insurance, and who will have access to your results.
• How results might impact your relatives and whether they may want testing too.

This is a great time to bring a list of questionsand, if you like, a family member or friend for extra support.

Step 3: Giving a DNA Sample

The actual sampling part is often the easiest step. Depending on your clinic and the testing program they use, your DNA
may be collected by:

• A blood draw from a vein in your arm.
• A saliva sample (spitting into a small tube).
• A bucal swab (rubbing the inside of your cheek with a soft swab).

Many modern IRD genetic testing panels look at hundreds of genes at onceoften 250 or morebecause so many genes can
cause similar retinal changes.

Step 4: What Happens in the Lab

Once your sample is shipped to the lab, specialists use advanced DNA sequencing technologies to “read” sections of your
genetic code and look for changes in IRD-associated genes.

High-quality tests are designed to capture hard-to-sequence regions (like the ORF15 region of the RPGR gene),
which are known hotspots for disease-causing variants in some forms of X-linked retinitis pigmentosa.

Lab scientists then interpret any variants they finddeciding whether they are:

• Pathogenic or likely pathogenic (known to cause disease).
• Benign or likely benign (not linked to disease).
• Variants of uncertain significance (VUS) – changes that are not yet fully understood.

This interpretation step is complex, and new research can sometimes reclassify variants over timeanother reason to stay
connected with your care team.

Step 5: Getting and Discussing Your Results

When your results are readyoften in a few weeks to a few monthsyou’ll meet again with your genetic counselor or
specialist. They’ll walk you through what was found and what it means in real life.

In broad terms, your results may fall into one of three buckets:

• Positive result – A disease-causing mutation is identified in a gene associated with IRD. This can:
  • Confirm your IRD diagnosis at the genetic level.
  • Clarify your inheritance pattern and family risks.
  • Help determine if you’re eligible for gene-specific therapies or clinical trials.
• Negative result – No disease-causing mutation is found in the genes tested. This does not
  mean your condition isn’t inherited; it may simply mean the responsible gene hasn’t been discovered yet, or the
  variant is in a region not covered by the test.
• Variant of uncertain significance (VUS) – A gene change is found, but current science can’t say
  for sure whether it causes disease. These results can sometimes be clarified with additional family testing or
  as new research emerges.

Many patients find it helpful to ask for a written summary of the results and their implications, both for their own
reference and to share with other doctors or family members.

How Accurate Is IRD Genetic Testing?

Thanks to major advances in sequencing technology, genetic testing can now identify the underlying genetic cause in
roughly 60–70% of people with inherited retinal disease, though the exact likelihood depends on the
specific condition, ancestry, and type of test.

This means:

• If you get a positive result, it’s usually highly reliable (with rare exceptions).
• If you get a negative or uncertain result today, new tests or re-analysis in the future may still uncover the answer.

In other words, a “no answer yet” result is frustratingbut not necessarily the end of the story.

Costs, Insurance, and No-Cost Testing Programs

The cost of IRD genetic testing can vary widely depending on your country, insurer, and the specific lab and panel used.
Some private tests may be expensive, but many patients do not end up paying the full sticker price.

Potential ways testing may be covered include:

• Health insurance coverage when testing meets medical-necessity criteria.
• Sponsored or “open access” programs supported by patient organizations and industry partners.
• Enrollment in research studies or registries that include testing as part of participation.

In the United States, for example, the Foundation Fighting Blindness offers the
My Retina Tracker® Genetic Testing Program, which provides no-cost diagnostic testing and genetic
counseling for people with a clinical diagnosis of IRD and helps connect them to a research registry.

Because policies and programs change frequently, it’s worth asking your eye specialist and genetic counselor about any
current optionswhether through national health systems, private insurance, or sponsored initiatives.

Questions to Ask Before You Get Tested

Walking into a genetics appointment with questions in hand can make the whole experience feel more in your control.
Consider asking:

• “Which genetic test are you recommending, and why?”
• “How likely is this test to find the cause of my retinal disease?”
• “What will happen if the result is uncertain or negative?”
• “Could my results change my treatment options or eligibility for clinical trials?”
• “How might these results affect my family members?”
• “Who will see my results, and how are they protected?”
• “Will there be any out-of-pocket costs for me?”

Remember: you’re allowed to take your time, think things over, and follow up with more questions later.

Coping With the Emotional Side of Testing

IRD genetic testing isn’t just a lab processit’s an emotional process. Some people feel relieved to finally have a name
for what they’re experiencing. Others feel anxious about what the results might mean for their children, siblings, or
future plans.

Common emotions include:

• Relief at having clear answers.
• Guilt or worry about passing on a gene (even though no one chooses their DNA).
• Fear about how fast vision might change.
• Hope about potential treatments or trials.

Talking with a genetic counselor, psychologist, or support grouponline or in personcan be incredibly helpful. Your
care team may be able to connect you with IRD-specific organizations, peer mentors, or low-vision rehabilitation
services that support both emotional and practical needs.

Real-World Experiences: What IRD Testing Feels Like in Everyday Life

The science of genetic testing is importantbut so is how it actually feels as a human being going through it.
Experiences vary widely, but a few themes show up again and again in people’s stories.

“At least now we know what we’re dealing with.”

Imagine Emma, a college student who has been struggling with night vision and bumping into things for years. Her
optometrist initially chalked it up to “being clumsy” and gave her a stronger glasses prescription. When she finally
sees a retinal specialist, she’s told she likely has retinitis pigmentosa. Genetic testing confirms a specific recessive
gene mutation.

The diagnosis is scary, but Emma feels oddly calmer after the results. Before testing, everything was unknown: Would she
wake up blind next year? Was she imagining things? With a genetic diagnosis, her doctor can give a more realistic sense
of how quickly her condition tends to progress in people with the same mutation, and what support and assistive
technology might help her stay in school and plan her career.

“Waiting for the results was harder than the test itself.”

Luis, a father of two young children, goes for IRD genetic testing after his teenage nephew is diagnosed with a retinal
dystrophy. The blood draw is simple; the hard part is the weeks of waiting. Every email notification and unknown phone
number sets his heart racing.

When the results finally arrive, Luis learns he carries one mutation but does not have the disease himself. That still
raises questions for his kids, and the genetic counselor helps him understand who might benefit from testing and when.
Luis realizes the emotional “limbo” while waiting was normaland that having a clear plan afterward makes the whole
experience feel worthwhile.

“It changed the conversation in our family.”

For Pat, a grandparent who has lived with progressive vision loss for decades, genetic testing comes later in life.
At first, they’re unsure what the point is; after all, their vision is already impaired, and there’s no “cure.”

But when the test confirms a specific autosomal dominant mutation, it suddenly reframes family history. The “bad eyes”
several relatives joked about over the years turn out to be part of a recognizable pattern. Pat’s adult children decide
to pursue testing, and some learn about their own status before symptoms appear. That knowledge shapes their choices
about careers, driving, and when to schedule regular eye exams for their own kids.

“Hope feels different when it’s tied to data.”

Another common theme is how people talk about hope after testing. Before genetic confirmation, hope can feel vaguelike
waiting for a miracle. After testing, hope can become more targeted: keeping an eye on a particular gene therapy trial,
joining the appropriate patient registry, or working with a low-vision specialist on specific strategies for school,
work, or daily life.

None of this erases the challenges of living with an inherited retinal disease, but it often shifts people from “nothing
can be done” to “here are the concrete steps I can take next.”

Putting It All Together

If you or someone you love has been diagnosed with (or is suspected of having) an inherited retinal disease, genetic
testing can feel like a big decision. It’s normal to have mixed feelings. But for many people, testing becomes a turning
pointa way to move from uncertainty to more personalized care, informed planning, and real opportunities to join the
wave of new research and therapies.

The process itself is usually simple: a referral, a counseling session, a sample, some waiting, and then a conversation
about what the results mean. What you do with those results is up to you, but you don’t have to figure it out alone.
Your eye specialist, genetic counselor, low-vision team, and patient support organizations can all help you navigate
the next steps.

You can’t change the genes you were born with. But by understanding them, you can make more informed decisions, advocate
for yourself, and tap into a growing network of tools, research, and community designed to support people with inherited
retinal diseasetoday and in the future.